Daniel Caput
12Patents
6h-index
26Co-inventors
66Inventor score
Filing activity: Jun 14, 1990 → Feb 15, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5652123A | Protein having interleukin 13 activity, recombinant DNA coding for this protein, transformed cells and microorganisms | Mechanical Engineering; Lighting; Heating | 43 | Expired |
| US5541098A | Urate oxidase activity protein, recombinant gene coding therefor, expression vector, micro-organisms and transformed cells | Chemistry; Metallurgy | 39 | Expired |
| US5382518A | Urate oxidase activity protein, recombinant gene coding therefor, expression vector, micro-organisms and transformed cells | Chemistry; Metallurgy | 39 | Expired |
| US6001649A | Chemokine NC28 (monocyte chemotactic protein-3, MCP-3) polypeptides and their recombinant production | Emerging Cross-Sectional Technologies | 26 | Expired |
| US7138505B1 | Factor VIII:C nucleic acid molecules | Chemistry; Metallurgy | 23 | Expired |
| US5045455A | Factor VIII:C cDNA cloning and expression | Human Necessities | 22 | Expired |
| US6022856A | Type-2 neurotensin receptor (NT-R2) | Human Necessities | 3 | Expired |
| US8318910B2 | IL-13 receptor antibodies | Human Necessities | 0 | Active |
| US7557187B2 | Purified SR-p70 protein | Chemistry; Metallurgy | 0 | Expired |
| US7838648B2 | Purified SR-p70 protein | Chemistry; Metallurgy | 0 | Active |
| US7928073B2 | Purified polypeptides having IL-13 receptor activity | Human Necessities | 0 | Active |
| US6274333A | Type-2 neurotensin receptor (NT-R2) | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.